Market Cap 4.84B
Revenue (ttm) 3.05B
Net Income (ttm) 69.68M
EPS (ttm) N/A
PE Ratio 7.85
Forward PE 7.92
Profit Margin 2.29%
Debt to Equity Ratio 0.70
Volume 619,200
Avg Vol 609,892
Day's Range N/A - N/A
Shares Out 44.19M
Stochastic %K 19%
Beta 1.05
Analysts Sell
Price Target $125.50

Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also of...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 610-225-6800
Address:
550 East Swedesford Road, Suite 400, Wayne, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:04 AM
$TFX is currently trading at $109.44, with a low RSI of 20.36, indicating it is significantly oversold. The 30-day moving average (MA30) is at $123.54, and the 50-day moving average (MA50) is at $124.28, suggesting a bearish trend as the price is well below both MAs. The recent 60-day high is $135.96 and the low is $102.58, providing a range that highlights potential volatility. Given the oversold RSI, there may be a short-term bullish reversal opportunity. Suggested entry is at $110.00, with a stop loss at $105.00 to manage risk. Target 1 is set at $115.00, aligning with the MA30, and Target 2 at $120.00, near the MA50. This plan aims to capitalize on a potential bounce while remaining cautious of the prevailing downtrend. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:37 AM
$TFX is currently trading at $109.44, with a low RSI of 20.36, indicating it is significantly oversold. The 30-day moving average (MA30) is at $123.54, and the 50-day moving average (MA50) is at $124.28, suggesting a bearish trend as the price is well below both MAs. The recent 60-day high is $135.96 and the low is $102.58, providing a range that highlights potential volatility. Given the oversold RSI, there may be a short-term bullish reversal opportunity. Suggested entry is at $110.00, with a stop loss at $105.00 to manage risk. Target 1 is set at $115.00, aligning with the MA30, and Target 2 at $120.00, near the MA50. This plan aims to capitalize on a potential bounce while remaining cautious of the prevailing downtrend. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:43 AM
$TFX is currently trading at $112.26, significantly below its 30-day moving average (MA30) of $124.49 and 50-day moving average (MA50) of $124.96, indicating a bearish trend. The RSI of 21.47 suggests that the stock is oversold, which may lead to a potential reversal in the near term. However, the recent price action is constrained within a 60-day high of $135.96 and a low of $102.58, establishing a clear range. For a trade plan, consider entering a long position near the lower end of this range, around $102.58, with a stop loss set at $100 to manage risk. Target 1 could be set at the MA30 of $124.49, while Target 2 could be the 60-day high of $135.96, allowing for a favorable risk-reward ratio. In summary, the directional bias is cautiously bullish due to the oversold RSI, but the overall trend remains bearish. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:19 AM
$TFX is currently trading at $112.26, significantly below its 30-day moving average (MA30) of $124.49 and 50-day moving average (MA50) of $124.96, indicating a bearish trend. The RSI of 21.47 suggests that the stock is oversold, which may lead to a potential reversal in the near term. However, the recent price action is constrained within a 60-day high of $135.96 and a low of $102.58, establishing a clear range. For a trade plan, consider entering a long position near the lower end of this range, around $102.58, with a stop loss set at $100 to manage risk. Target 1 could be set at the MA30 of $124.49, while Target 2 could be the 60-day high of $135.96, allowing for a favorable risk-reward ratio. In summary, the directional bias is cautiously bullish due to the oversold RSI, but the overall trend remains bearish. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 5:09 PM
Truist Securities updates rating for Teleflex ( $TFX ) to Hold, target set at 128 → 120.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 11:14 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 7:31 PM
RBC Capital has updated their rating for Teleflex ( $TFX ) to Sector Perform with a price target of 120.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:48 PM
Wells Fargo has updated their rating for Teleflex ( $TFX ) to Equal-Weight with a price target of 114.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 6 at 5:58 PM
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 3 at 3:11 PM
$TFX Share Price: $121.98 Contract Selected: Apr 17, 2026 $120 Calls Buy Zone: $11.13 – $13.76 Target Zone: $18.12 – $22.14 Potential Upside: 54% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Latest News on TFX
Teleflex Incorporated (TFX) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 11:16 AM EST - 8 days ago

Teleflex Incorporated (TFX) Q3 2025 Earnings Call Transcript


Teleflex Announces Quarterly Dividend

Nov 6, 2025, 6:45 AM EST - 8 days ago

Teleflex Announces Quarterly Dividend


Teleflex Publishes 2024 Global Impact Report

May 19, 2025, 6:30 AM EDT - 6 months ago

Teleflex Publishes 2024 Global Impact Report


Teleflex Incorporated (TFX) Q1 2025 Earnings Call Transcript

May 1, 2025, 3:13 PM EDT - 7 months ago

Teleflex Incorporated (TFX) Q1 2025 Earnings Call Transcript


PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:04 AM
$TFX is currently trading at $109.44, with a low RSI of 20.36, indicating it is significantly oversold. The 30-day moving average (MA30) is at $123.54, and the 50-day moving average (MA50) is at $124.28, suggesting a bearish trend as the price is well below both MAs. The recent 60-day high is $135.96 and the low is $102.58, providing a range that highlights potential volatility. Given the oversold RSI, there may be a short-term bullish reversal opportunity. Suggested entry is at $110.00, with a stop loss at $105.00 to manage risk. Target 1 is set at $115.00, aligning with the MA30, and Target 2 at $120.00, near the MA50. This plan aims to capitalize on a potential bounce while remaining cautious of the prevailing downtrend. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:37 AM
$TFX is currently trading at $109.44, with a low RSI of 20.36, indicating it is significantly oversold. The 30-day moving average (MA30) is at $123.54, and the 50-day moving average (MA50) is at $124.28, suggesting a bearish trend as the price is well below both MAs. The recent 60-day high is $135.96 and the low is $102.58, providing a range that highlights potential volatility. Given the oversold RSI, there may be a short-term bullish reversal opportunity. Suggested entry is at $110.00, with a stop loss at $105.00 to manage risk. Target 1 is set at $115.00, aligning with the MA30, and Target 2 at $120.00, near the MA50. This plan aims to capitalize on a potential bounce while remaining cautious of the prevailing downtrend. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:43 AM
$TFX is currently trading at $112.26, significantly below its 30-day moving average (MA30) of $124.49 and 50-day moving average (MA50) of $124.96, indicating a bearish trend. The RSI of 21.47 suggests that the stock is oversold, which may lead to a potential reversal in the near term. However, the recent price action is constrained within a 60-day high of $135.96 and a low of $102.58, establishing a clear range. For a trade plan, consider entering a long position near the lower end of this range, around $102.58, with a stop loss set at $100 to manage risk. Target 1 could be set at the MA30 of $124.49, while Target 2 could be the 60-day high of $135.96, allowing for a favorable risk-reward ratio. In summary, the directional bias is cautiously bullish due to the oversold RSI, but the overall trend remains bearish. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:19 AM
$TFX is currently trading at $112.26, significantly below its 30-day moving average (MA30) of $124.49 and 50-day moving average (MA50) of $124.96, indicating a bearish trend. The RSI of 21.47 suggests that the stock is oversold, which may lead to a potential reversal in the near term. However, the recent price action is constrained within a 60-day high of $135.96 and a low of $102.58, establishing a clear range. For a trade plan, consider entering a long position near the lower end of this range, around $102.58, with a stop loss set at $100 to manage risk. Target 1 could be set at the MA30 of $124.49, while Target 2 could be the 60-day high of $135.96, allowing for a favorable risk-reward ratio. In summary, the directional bias is cautiously bullish due to the oversold RSI, but the overall trend remains bearish. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 5:09 PM
Truist Securities updates rating for Teleflex ( $TFX ) to Hold, target set at 128 → 120.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 11:14 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 7:31 PM
RBC Capital has updated their rating for Teleflex ( $TFX ) to Sector Perform with a price target of 120.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:48 PM
Wells Fargo has updated their rating for Teleflex ( $TFX ) to Equal-Weight with a price target of 114.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 6 at 5:58 PM
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 3 at 3:11 PM
$TFX Share Price: $121.98 Contract Selected: Apr 17, 2026 $120 Calls Buy Zone: $11.13 – $13.76 Target Zone: $18.12 – $22.14 Potential Upside: 54% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 31 at 11:57 AM
$TFX RSI: 60.95, MACD: 1.2773 Vol: 4.42, MA20: 127.53, MA50: 126.63 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 3 at 8:20 PM
$TFX Share Price: $130.95 Contract Selected: Jan 16, 2026 $130 Calls Buy Zone: $9.43 – $11.65 Target Zone: $17.44 – $21.31 Potential Upside: 75% ROI Time to Expiration: 104 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
JackDarwin
JackDarwin Sep. 27 at 10:45 AM
$TFX Bullish Harami Candlestick Pattern.
0 · Reply
ZacksResearch
ZacksResearch Aug. 21 at 2:50 PM
$TFX jumps 3.7% following new product launch! 🚀 Teleflex's Barrigel rectal spacer gets the green light in Japan, marking a key milestone in its global push. With a solid market sentiment boost and an impressive 11.3% earnings yield compared to the industry’s -5.2%, TFX is well-positioned against industry headwinds. See what makes the investment case strong for TFX 👉 https://www.zacks.com/stock/news/2740846/teleflex-stock-gains-following-barrigels-launch-in-japan?cid=sm-stocktwits-2-2740846-body-8798&ADID=SYND_STOCKTWITS_TWEET_2_2740846_BODY_8798
0 · Reply
ZacksResearch
ZacksResearch Aug. 21 at 1:50 PM
$TFX breaks out on global expansion move 🌏 Shares popped 3.7% after the launch of Barrigel in Japan — a clear milestone in the company’s worldwide growth strategy. Full breakdown here 👉 https://www.zacks.com/stock/news/2740846/teleflex-stock-gains-following-barrigels-launch-in-japan?cid=sm-stocktwits-2-2740846-teaser-8797&ADID=SYND_STOCKTWITS_TWEET_2_2740846_TEASER_8797
0 · Reply
MapTechnicalForecasting
MapTechnicalForecasting Aug. 20 at 3:01 AM
$TFX starting to look tempting 🤔
0 · Reply
inelegantinvest
inelegantinvest Aug. 19 at 10:21 PM
Teleflex is charting a new course—splitting into two focused medtech companies by mid-2026. RemainCo keeps vascular, interventional & surgical lines. NewCo inherits urology, acute care & OEM design/manufacturing. Tax-free spin, double-digit EPS growth expected. Dive deeper ⤵ https://www.stockspinoffs.com/2025/08/19/teleflex-spinoff-of-urology-acute-care-and-oem-businesses-expected-in-mid-2026/ $TFX #teleflex
0 · Reply
NeveREn0ugH
NeveREn0ugH Aug. 12 at 2:43 PM
$TFX accumulation
0 · Reply
NeveREn0ugH
NeveREn0ugH Aug. 6 at 6:39 PM
$TFX whats up w this!?
1 · Reply
scientificway
scientificway Aug. 4 at 7:25 PM
$TFX My recomandation MDXG, huge rev, eps, guidance up. , guidance is so good, how much after a year
0 · Reply
IN0V8
IN0V8 Aug. 4 at 3:45 PM
$TFX Truist Securities raises target price to $128 from $123
0 · Reply
scientificway
scientificway Aug. 3 at 4:25 AM
$TFX check MDXG out, last chance below 7.2, explosion due to rev. eps surprise
0 · Reply